1ZRZ - Header Asymmetric Unit

HEADER TRANSFERASE 23-MAY-05 1ZRZ

TITLE CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF ATYPICAL TITLE 2 PROTEIN KINASE C-IOTA

COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN KINASE C, IOTA; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 224-587; COMPND 5 EC: 2.7.1.-; COMPND 6 ENGINEERED: YES

SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PRKCI; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: SF9 CELLS; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PFASTBACHTA

KEYWDS PROTEIN-INHIBITOR COMPLEX, STRUCTURAL GENOMICS, STRUCTURAL KEYWDS 2 PROTEOMICS IN EUROPE, SPINE, TRANSFERASE

EXPDTA X-RAY DIFFRACTION

AUTHOR A.MESSERSCHMIDT,S.MACIEIRA,M.VELARDE,M.BAEDEKER,C.BENDA, AUTHOR 2 A.JESTEL,H.BRANDSTETTER,T.NEUEFEIND,M.BLAESSE,STRUCTURAL AUTHOR 3 PROTEOMICS IN EUROPE (SPINE)

REVDAT 3 24-FEB-09 1ZRZ 1 VERSN REVDAT 2 27-SEP-05 1ZRZ 1 JRNL REVDAT 1 13-SEP-05 1ZRZ 0

JRNL AUTH A.MESSERSCHMIDT,S.MACIEIRA,M.VELARDE,M.BAEDEKER, JRNL AUTH 2 C.BENDA,A.JESTEL,H.BRANDSTETTER,T.NEUEFEIND, JRNL AUTH 3 M.BLAESSE JRNL TITL CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JRNL TITL 2 ATYPICAL PROTEIN KINASE C-IOTA REVEALS INTERACTION JRNL TITL 3 MODE OF PHOSPHORYLATION SITE IN TURN MOTIF JRNL REF J.MOL.BIOL. V. 352 918 2005 JRNL REFN ISSN 0022-2836 JRNL PMID 16125198 JRNL DOI 10.1016/J.JMB.2005.07.060

REMARK 1

REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.94 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 3637087.060 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 90.2 REMARK 3 NUMBER OF REFLECTIONS : 7517 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.249 REMARK 3 FREE R VALUE : 0.333 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 394 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.017 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.19 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1270 REMARK 3 BIN R VALUE (WORKING SET) : 0.2870 REMARK 3 BIN FREE R VALUE : 0.4010 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 68 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.049 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2450 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 31 REMARK 3 SOLVENT ATOMS : 42 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 59.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 59.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -9.08000 REMARK 3 B22 (A**2) : -9.08000 REMARK 3 B33 (A**2) : 18.17000 REMARK 3 B12 (A**2) : 5.95000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.44 REMARK 3 ESD FROM SIGMAA (A) : 0.35 REMARK 3 LOW RESOLUTION CUTOFF (A) : 6.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.58 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.61 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.50 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.50 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.89 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.490 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.580 ; 2.500 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.910 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.050 ; 3.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.32 REMARK 3 BSOL : 51.49 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : TPO.PAR REMARK 3 PARAMETER FILE 5 : BI1.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : TPO.TOP REMARK 3 TOPOLOGY FILE 5 : BI1.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL

REMARK 4 REMARK 4 1ZRZ COMPLIES WITH FORMAT V. 3.15, 01-DEC-08

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-JUN-05. REMARK 100 THE RCSB ID CODE IS RCSB033049.

REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-AUG-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0003 REMARK 200 MONOCHROMATOR : SILICON MONOCHROMATOR REMARK 200 OPTICS : SILICON MONOCHROMATOR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 7778 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 37.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.9 REMARK 200 DATA REDUNDANCY : 5.700 REMARK 200 R MERGE (I) : 0.09300 REMARK 200 R SYM (I) : 0.09300 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 6.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.19 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.10 REMARK 200 R MERGE FOR SHELL (I) : 0.37100 REMARK 200 R SYM FOR SHELL (I) : 0.37100 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PROTEIN KINASE C-THATE, PDB ENTRY 1XJD REMARK 200 REMARK 200 REMARK: NULL

REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.48 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 400, SODIUM ACETATE, MES, PH REMARK 280 6.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K

REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 75.08333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 37.54167 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 37.54167 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 75.08333 REMARK 290 REMARK 290 REMARK: NULL

REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.

REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000

REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 224 REMARK 465 LYS A 225 REMARK 465 GLU A 226 REMARK 465 ALA A 227 REMARK 465 MET A 228 REMARK 465 ASN A 229 REMARK 465 THR A 230 REMARK 465 ARG A 231 REMARK 465 GLU A 232 REMARK 465 SER A 233 REMARK 465 GLY A 234 REMARK 465 LYS A 235 REMARK 465 ALA A 236 REMARK 465 SER A 237 REMARK 465 SER A 238 REMARK 465 SER A 239 REMARK 465 ILE A 446 REMARK 465 VAL A 447 REMARK 465 GLY A 448 REMARK 465 SER A 449 REMARK 465 SER A 450 REMARK 465 ASP A 451 REMARK 465 ASN A 452 REMARK 465 PRO A 453 REMARK 465 ASP A 454 REMARK 465 ASN A 533 REMARK 465 ILE A 534 REMARK 465 SER A 535 REMARK 465 GLY A 536 REMARK 465 GLU A 537 REMARK 465 PHE A 538 REMARK 465 GLY A 539 REMARK 465 LEU A 540 REMARK 465 ASP A 541 REMARK 465 ASN A 542 REMARK 465 PHE A 543 REMARK 465 ASP A 544 REMARK 465 SER A 545 REMARK 465 GLN A 546 REMARK 465 PHE A 547 REMARK 465 THR A 548 REMARK 465 ASN A 549 REMARK 465 GLU A 550 REMARK 465 ARG A 551 REMARK 465 LEU A 580 REMARK 465 MET A 581 REMARK 465 SER A 582 REMARK 465 ALA A 583 REMARK 465 GLU A 584 REMARK 465 GLU A 585 REMARK 465 CYS A 586 REMARK 465 VAL A 587

REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS(M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 240 CG CD1 CD2 REMARK 470 GLN A 243 CG CD OE1 NE2 REMARK 470 LYS A 258 CG CD CE NZ REMARK 470 LYS A 266 CG CD CE NZ REMARK 470 LYS A 278 CG CD CE NZ REMARK 470 ASP A 283 CG OD1 OD2 REMARK 470 ASP A 284 CG OD1 OD2 REMARK 470 ARG A 337 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 339 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 441 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 445 CG OD1 OD2 REMARK 470 GLU A 467 CG CD OE1 OE2 REMARK 470 LYS A 468 CG CD CE NZ REMARK 470 ARG A 471 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 479 CG CD CE NZ REMARK 470 LYS A 485 CG CD CE NZ REMARK 470 GLN A 501 CG CD OE1 NE2 REMARK 470 LYS A 524 CG CD CE NZ REMARK 470 GLN A 525 CG CD OE1 NE2 REMARK 470 LYS A 531 CG CD CE NZ REMARK 470 VAL A 552 CG1 CG2 REMARK 470 GLN A 553 CG CD OE1 NE2 REMARK 470 ASP A 558 CG OD1 OD2 REMARK 470 ARG A 563 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 564 CG CD CE NZ REMARK 470 LEU A 579 CG CD1 CD2

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 243 -78.69 -40.02 REMARK 500 ASP A 244 14.31 -54.15 REMARK 500 ASP A 268 -2.38 73.78 REMARK 500 GLU A 279 3.46 -53.78 REMARK 500 VAL A 281 66.00 -115.12 REMARK 500 ASP A 283 141.84 99.80 REMARK 500 GLU A 298 34.14 -85.62 REMARK 500 GLN A 299 -34.51 -156.84 REMARK 500 ASN A 327 32.41 -145.07 REMARK 500 GLN A 338 -6.23 -147.68 REMARK 500 ARG A 339 -92.17 69.75 REMARK 500 ARG A 368 -15.36 63.34 REMARK 500 LYS A 384 109.25 -163.09 REMARK 500 ASP A 387 118.73 64.45 REMARK 500 MET A 390 6.88 -163.79 REMARK 500 GLU A 393 -179.13 -69.84 REMARK 500 LEU A 395 118.00 179.67 REMARK 500 CYS A 405 -165.87 -163.12 REMARK 500 PRO A 408 -57.00 -26.14 REMARK 500 ARG A 417 6.24 -68.69 REMARK 500 ASN A 456 154.76 101.98 REMARK 500 THR A 457 -103.84 -40.53 REMARK 500 ASP A 459 -74.34 -30.06 REMARK 500 GLU A 467 -42.67 -143.14 REMARK 500 MET A 476 157.74 -48.86 REMARK 500 LEU A 488 30.89 -99.81 REMARK 500 GLU A 494 11.96 -58.16 REMARK 500 GLN A 501 4.47 49.57 REMARK 500 PHE A 513 49.46 -106.91 REMARK 500 PRO A 529 5.82 -69.07 REMARK 500 PHE A 530 107.69 -167.99 REMARK 500 GLN A 567 -23.63 58.47 REMARK 500 GLU A 569 44.85 -66.35 REMARK 500 PHE A 570 26.81 -141.92 REMARK 500 TYR A 575 124.16 178.25 REMARK 500 REMARK 500 REMARK: NULL

REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BI1 A 1000

REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1XJD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PKC-THETA

DBREF 1ZRZ A 224 587 UNP P41743 KPCI_HUMAN 224 587

SEQADV 1ZRZ TPO A 403 UNP P41743 THR 403 MODIFIED RESIDUE SEQADV 1ZRZ TPO A 555 UNP P41743 THR 555 MODIFIED RESIDUE

SEQRES 1 A 364 GLU LYS GLU ALA MET ASN THR ARG GLU SER GLY LYS ALA SEQRES 2 A 364 SER SER SER LEU GLY LEU GLN ASP PHE ASP LEU LEU ARG SEQRES 3 A 364 VAL ILE GLY ARG GLY SER TYR ALA LYS VAL LEU LEU VAL SEQRES 4 A 364 ARG LEU LYS LYS THR ASP ARG ILE TYR ALA MET LYS VAL SEQRES 5 A 364 VAL LYS LYS GLU LEU VAL ASN ASP ASP GLU ASP ILE ASP SEQRES 6 A 364 TRP VAL GLN THR GLU LYS HIS VAL PHE GLU GLN ALA SER SEQRES 7 A 364 ASN HIS PRO PHE LEU VAL GLY LEU HIS SER CYS PHE GLN SEQRES 8 A 364 THR GLU SER ARG LEU PHE PHE VAL ILE GLU TYR VAL ASN SEQRES 9 A 364 GLY GLY ASP LEU MET PHE HIS MET GLN ARG GLN ARG LYS SEQRES 10 A 364 LEU PRO GLU GLU HIS ALA ARG PHE TYR SER ALA GLU ILE SEQRES 11 A 364 SER LEU ALA LEU ASN TYR LEU HIS GLU ARG GLY ILE ILE SEQRES 12 A 364 TYR ARG ASP LEU LYS LEU ASP ASN VAL LEU LEU ASP SER SEQRES 13 A 364 GLU GLY HIS ILE LYS LEU THR ASP TYR GLY MET CYS LYS SEQRES 14 A 364 GLU GLY LEU ARG PRO GLY ASP THR THR SER TPO PHE CYS SEQRES 15 A 364 GLY THR PRO ASN TYR ILE ALA PRO GLU ILE LEU ARG GLY SEQRES 16 A 364 GLU ASP TYR GLY PHE SER VAL ASP TRP TRP ALA LEU GLY SEQRES 17 A 364 VAL LEU MET PHE GLU MET MET ALA GLY ARG SER PRO PHE SEQRES 18 A 364 ASP ILE VAL GLY SER SER ASP ASN PRO ASP GLN ASN THR SEQRES 19 A 364 GLU ASP TYR LEU PHE GLN VAL ILE LEU GLU LYS GLN ILE SEQRES 20 A 364 ARG ILE PRO ARG SER MET SER VAL LYS ALA ALA SER VAL SEQRES 21 A 364 LEU LYS SER PHE LEU ASN LYS ASP PRO LYS GLU ARG LEU SEQRES 22 A 364 GLY CYS LEU PRO GLN THR GLY PHE ALA ASP ILE GLN GLY SEQRES 23 A 364 HIS PRO PHE PHE ARG ASN VAL ASP TRP ASP MET MET GLU SEQRES 24 A 364 GLN LYS GLN VAL VAL PRO PRO PHE LYS PRO ASN ILE SER SEQRES 25 A 364 GLY GLU PHE GLY LEU ASP ASN PHE ASP SER GLN PHE THR SEQRES 26 A 364 ASN GLU ARG VAL GLN LEU TPO PRO ASP ASP ASP ASP ILE SEQRES 27 A 364 VAL ARG LYS ILE ASP GLN SER GLU PHE GLU GLY PHE GLU SEQRES 28 A 364 TYR ILE ASN PRO LEU LEU MET SER ALA GLU GLU CYS VAL

MODRES 1ZRZ TPO A 403 THR PHOSPHOTHREONINE MODRES 1ZRZ TPO A 555 THR PHOSPHOTHREONINE

HET TPO A 403 11 HET TPO A 555 11 HET BI1 A1000 31

HETNAM TPO PHOSPHOTHREONINE HETNAM BI1 3-{1-[3-(DIMETHYLAMINO)PROPYL]-1H-INDOL-3-YL}-4-(1H- HETNAM 2 BI1 INDOL-3-YL)-1H-PYRROLE-2,5-DIONE

HETSYN TPO PHOSPHONOTHREONINE HETSYN BI1 RBT205 INHIBITOR

FORMUL 1 TPO 2(C4 H10 N O6 P) FORMUL 2 BI1 C25 H24 N4 O2 FORMUL 3 HOH *42(H2 O)

HELIX 1 1 GLU A 279 VAL A 281 5 3 HELIX 2 2 ASP A 286 GLU A 298 1 13 HELIX 3 3 ASP A 330 ARG A 337 1 8 HELIX 4 4 PRO A 342 ARG A 363 1 22 HELIX 5 5 LYS A 371 ASP A 373 5 3 HELIX 6 6 THR A 407 ILE A 411 5 5 HELIX 7 7 ALA A 412 ARG A 417 1 6 HELIX 8 8 PHE A 423 GLY A 440 1 18 HELIX 9 9 ASN A 456 LYS A 468 1 13 HELIX 10 10 SER A 477 LEU A 488 1 12 HELIX 11 11 THR A 502 HIS A 510 1 9 HELIX 12 12 PRO A 511 ARG A 514 5 4 HELIX 13 13 ASP A 517 GLU A 522 1 6 HELIX 14 14 ASP A 558 ARG A 563 1 6 HELIX 15 15 GLN A 567 GLU A 571 5 5

SHEET 1 A 6 PHE A 245 ARG A 253 0 SHEET 2 A 6 ALA A 257 LEU A 264 -1 O VAL A 259 N GLY A 252 SHEET 3 A 6 ILE A 270 LYS A 277 -1 O VAL A 275 N LYS A 258 SHEET 4 A 6 ARG A 318 GLU A 324 -1 O LEU A 319 N VAL A 276 SHEET 5 A 6 LEU A 309 CYS A 312 -1 N SER A 311 O VAL A 322 SHEET 6 A 6 TYR A 575 ILE A 576 -1 O TYR A 575 N CYS A 312 SHEET 1 B 2 VAL A 375 LEU A 377 0 SHEET 2 B 2 ILE A 383 LEU A 385 -1 O LYS A 384 N LEU A 376

LINK C SER A 402 N TPO A 403 1555 1555 1.34 LINK C TPO A 403 N PHE A 404 1555 1555 1.34 LINK C LEU A 554 N TPO A 555 1555 1555 1.35 LINK C TPO A 555 N PRO A 556 1555 1555 1.34

SITE 1 AC1 15 ILE A 251 GLY A 252 VAL A 259 ALA A 272 SITE 2 AC1 15 LYS A 274 VAL A 307 ILE A 323 GLU A 324 SITE 3 AC1 15 TYR A 325 VAL A 326 ASP A 330 ASP A 373 SITE 4 AC1 15 LEU A 376 THR A 386 ASP A 387

CRYST1 78.143 78.143 112.625 90.00 90.00 120.00 P 32 2 1 6

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 0.012797 0.007388 0.000000 0.00000

SCALE2 0.000000 0.014777 0.000000 0.00000

SCALE3 0.000000 0.000000 0.008879 0.00000